Simon Michel, Ypsomed CEO: “There is a large pool of qualified people in Barcelona”
24 May 2022
Business Investments · Life Sciences
The Swiss medtech company Ypsomed is a world leader in manufacturing insulin pens. Ypsomed has chosen Barcelona to open its first R&D center outside Switzerland and expects to build a workforce of 60 people over the next year.
CEO Simon Michel explains in this interview how, from Barcelona, the company will do everything that involves digitalizing its devices. Finding the best talent pool in Catalonia was a determining factor for the new investment, as well as sharing the same cultural values.
Simon Michel also highlights the support Ypsomed received from Catalonia Trade & Investment to find the right location and to undergo the recruiting process.
Interested in investing in Barcelona - Catalonia?
We are the one-stop shop for international companies looking to establish or expand their operations in Catalonia. Contact us and we will help you grow.
Check out our services.
Business Location Service
Get all the information about industrial buildings, land, business centers, or office spaces in Barcelona-Catalonia.
Access to talent
Access to all sources of available talent for international companies in Barcelona-Catalonia.
International Mobility for Executives
We will guide you through the international mobility process from start to finish.
Related news and success stories.
02 Jun 2023
Rockwell Automation opens new offices in the Barcelona 22@ district
02 Jun 2023
Bold will invest 25 million euros in boosting growth in electric battery production
26 May 2023
Barcelona ranks as the world's 1st city for conference attendees
24 May 2023
Barcelona consolidates its position in the world's top executive education rankings, with three schools in the top 25